Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Dugo, Matteo"'
Autor:
Guardia C; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Bianchini G; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Arpí-LLucià O; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Menendez S; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Casadevall D; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Galbardi B; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Dugo M; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Servitja S; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Montero JC; Centro de Investigación del Cáncer, IBSAL-CSIC-CIBERONC, Salamanca, Spain., Soria-Jiménez L; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Sabbaghi M; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Peña R; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain., Madoz-Gúrpide J; Department of Pathology, IIS-Fundación Jiménez Díaz-CIBERONC, Madrid, Spain., Lloveras B; Department of Pathology, Hospital del Mar, Barcelona, Spain., Lluch A; INCLIVA Biomedical Research Institute, Hospital Clínico de Valencia-CIBERONC, Universitat de València, Barcelona, Spain., Eroles P; INCLIVA Biomedical Research Institute, Hospital Clínico de Valencia-CIBERONC, Universitat de València, Barcelona, Spain.; INCLIVA, Biomedical Research Institute, Valencia, Spain., Arribas J; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., Pandiella A; Centro de Investigación del Cáncer, IBSAL-CSIC-CIBERONC, Salamanca, Spain., Gianni L; Fondazione Gianni Bonadonna, Milan, Italy., Rojo F; Department of Pathology, IIS-Fundación Jiménez Díaz-CIBERONC, Madrid, Spain., Rovira A; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Albanell J; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. jalbanell@hospitaldelmar.cat.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Sep 15; Vol. 27 (18), pp. 5096-5108. Date of Electronic Publication: 2021 Aug 12.
Autor:
Ligorio, Francesca, Cosimo, Serena Di, Verderio, Paolo, Ciniselli, Chiara Maura, Pizzamiglio, Sara, Castagnoli, Lorenzo, Dugo, Matteo, Galbardi, Barbara, Salgado, Roberto, Loi, Sherene, Michiels, Stefan, Triulzi, Tiziana, Tagliabue, Elda, El-Abed, Sarra, Izquierdo, Miguel, Azambuja, Evandro de, Nuciforo, Paolo, Huober, Jens, Moscetti, Luca, Janni, Wolfgang
Publikováno v:
JNCI: Journal of the National Cancer Institute; Dec2022, Vol. 114 Issue 12, p1720-1727, 8p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Triulzi, Tiziana, Bianchini, Giampaolo, Di Cosimo, Serena, Pienkowski, Tadeusz, Young-Hyuck Im, Bianchi, Giulia Valeria, Galbardi, Barbara, Dugo, Matteo, De Cecco, Loris, Ling-Ming Tseng, Mei-Ching Liu, Bermejo, Begoña, Semiglazov, Vladimir, Viale, Giulia, de la Haba-Rodriguez, Juan, Do-Youn Oh, Poirier, Brigitte, Valagussa, Pinuccia, Gianni, Luca, Tagliabue, Elda
Publikováno v:
Molecular Oncology; Jun2022, Vol. 16 Issue 12, p2355-2366, 17p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rossella Canese, Elda Tagliabue, Patrizia Nanni, Egidio Iorio, Daniele Morelli, Massimo Di Nicola, Simona Faraci, Patrizia Casalini, Lorenzo Castagnoli, Matteo Dugo, Claudio Vernieri, Ada Koschorke, Serenella M. Pupa
Publikováno v:
Journal of Cellular Physiology
Despite different molecular tumor profiles indicate that human epidermal growth factor receptor 2 (HER2) messenger RNA (mRNA) levels mirror HER2 addiction and trastuzumab benefit in HER2-positive breast cancer (BC), the identification of noninvasive